Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethicone for prevention of ileus in patients with pelvic or femoral fractures
IRCT20200708048064N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dimeticone in ileus (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Incidence of ileus in observation and intervention group. Started Nov 2020; status: completed.
02
Drugs
dimeticone
03
Conditions
ileus
Beyond the preview
Go deeper on IRCT20200708048064N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200708048064N1.